| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 3e-05 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |